TRUE Private Wealth Advisors’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-46
Closed -$5K 541
2020
Q4
$5K Hold
46
﹤0.01% 608
2020
Q3
$4K Buy
+46
New +$5.6K ﹤0.01% 584

Other funds holding NVAX

TRUE Private Wealth Advisors's NVAX Position: Q1 2021 in Review

TRUE Private Wealth Advisors sold out of Novavax (NVAX) in Q1 2021, closing a stake of 46 shares — an estimated $5K sold.

TRUE Private Wealth Advisors first reported a position in NVAX in Q3 2020 and held it in 2 quarters. The position peaked at $5K in Q4 2020. 389 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

  • TRUE Private Wealth Advisors reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 46 Novavax shares in Q1 2021, an estimated $5K.
  • TRUE Private Wealth Advisors first reported a position in Novavax in Q3 2020 and held it in 2 quarters.
  • TRUE Private Wealth Advisors's Novavax position peaked at $5K in Q4 2020.
  • 389 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on TRUE Private Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.